PaxMedica IncNASDAQ:PXMDNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE2.4300
- TODAY'S CHANGE (%)-0.2700 (-10.0000%)
- Bid / Lots2.3800/ 5
- Ask / Lots2.4900/ 3
- Open / Previous Close2.7300 / 2.7000
- Day Range
- 52 Week Range
- Volume374,655
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PXMD |
|---|---|---|
| 09:32 ET | 10782 | 2.65 |
| 09:33 ET | 500 | 2.656 |
| 09:35 ET | 848 | 2.62 |
| 09:37 ET | 3720 | 2.53 |
| 09:39 ET | 928 | 2.575 |
| 09:42 ET | 1367 | 2.57 |
| 09:44 ET | 560 | 2.58 |
| 09:46 ET | 3573 | 2.61 |
| 09:48 ET | 1678 | 2.5813 |
| 09:50 ET | 1400 | 2.585 |
| 09:51 ET | 1250 | 2.5817 |
| 09:53 ET | 1910 | 2.62 |
| 09:55 ET | 640 | 2.5993 |
| 09:57 ET | 400 | 2.595 |
| 10:00 ET | 3300 | 2.5989 |
| 10:02 ET | 5102 | 2.59 |
| 10:04 ET | 10083 | 2.5765 |
| 10:06 ET | 1100 | 2.5643 |
| 10:08 ET | 900 | 2.5503 |
| 10:09 ET | 700 | 2.54 |
| 10:11 ET | 940 | 2.56 |
| 10:13 ET | 5518 | 2.6 |
| 10:20 ET | 2397 | 2.58 |
| 10:22 ET | 894 | 2.5648 |
| 10:24 ET | 100 | 2.5501 |
| 10:26 ET | 4045 | 2.53 |
| 10:27 ET | 392 | 2.53 |
| 10:31 ET | 6863 | 2.46 |
| 10:33 ET | 3926 | 2.46 |
| 10:36 ET | 3237 | 2.5 |
| 10:38 ET | 1500 | 2.475 |
| 10:42 ET | 225 | 2.4883 |
| 10:44 ET | 300 | 2.47 |
| 10:45 ET | 3033 | 2.4622 |
| 10:47 ET | 3476 | 2.48 |
| 10:49 ET | 801 | 2.4729 |
| 10:51 ET | 500 | 2.4767 |
| 10:54 ET | 100 | 2.47 |
| 10:56 ET | 500 | 2.4501 |
| 10:58 ET | 6883 | 2.42 |
| 11:00 ET | 18066 | 2.34 |
| 11:02 ET | 3739 | 2.3756 |
| 11:03 ET | 2724 | 2.4167 |
| 11:05 ET | 300 | 2.43 |
| 11:07 ET | 1705 | 2.4242 |
| 11:09 ET | 15400 | 2.4299 |
| 11:14 ET | 808 | 2.4425 |
| 11:16 ET | 5300 | 2.46 |
| 11:18 ET | 220 | 2.49 |
| 11:20 ET | 318 | 2.49 |
| 11:21 ET | 5099 | 2.52 |
| 11:23 ET | 400 | 2.5193 |
| 11:25 ET | 1200 | 2.53 |
| 11:30 ET | 1200 | 2.53 |
| 11:32 ET | 6550 | 2.52 |
| 11:34 ET | 12116 | 2.5185 |
| 11:36 ET | 2500 | 2.51 |
| 11:38 ET | 1910 | 2.5097 |
| 11:39 ET | 2633 | 2.51 |
| 11:41 ET | 500 | 2.5083 |
| 11:45 ET | 900 | 2.505 |
| 11:52 ET | 100 | 2.51 |
| 11:54 ET | 266 | 2.5101 |
| 11:56 ET | 600 | 2.53 |
| 11:57 ET | 1300 | 2.53 |
| 11:59 ET | 584 | 2.53 |
| 12:01 ET | 443 | 2.52 |
| 12:08 ET | 100 | 2.511 |
| 12:10 ET | 2522 | 2.5101 |
| 12:12 ET | 785 | 2.51 |
| 12:14 ET | 600 | 2.5094 |
| 12:17 ET | 200 | 2.5097 |
| 12:19 ET | 100 | 2.5 |
| 12:24 ET | 3445 | 2.51 |
| 12:28 ET | 1800 | 2.5079 |
| 12:30 ET | 600 | 2.51 |
| 12:32 ET | 100 | 2.5 |
| 12:33 ET | 600 | 2.5 |
| 12:37 ET | 3466 | 2.5099 |
| 12:39 ET | 1369 | 2.5 |
| 12:42 ET | 400 | 2.5 |
| 12:44 ET | 5081 | 2.46 |
| 12:46 ET | 266 | 2.485 |
| 12:48 ET | 2420 | 2.47 |
| 12:50 ET | 650 | 2.4527 |
| 12:53 ET | 315 | 2.47 |
| 12:55 ET | 100 | 2.47 |
| 12:57 ET | 5417 | 2.49 |
| 01:00 ET | 100 | 2.49 |
| 01:02 ET | 200 | 2.51 |
| 01:04 ET | 500 | 2.49 |
| 01:06 ET | 100 | 2.52 |
| 01:08 ET | 309 | 2.52 |
| 01:09 ET | 100 | 2.52 |
| 01:11 ET | 332 | 2.51 |
| 01:18 ET | 100 | 2.52 |
| 01:22 ET | 113 | 2.5102 |
| 01:26 ET | 100 | 2.53 |
| 01:27 ET | 100 | 2.53 |
| 01:31 ET | 700 | 2.51 |
| 01:38 ET | 1000 | 2.53 |
| 01:40 ET | 325 | 2.54 |
| 01:42 ET | 2926 | 2.5485 |
| 01:44 ET | 4685 | 2.54 |
| 01:47 ET | 528 | 2.5373 |
| 01:51 ET | 200 | 2.55 |
| 01:54 ET | 100 | 2.555 |
| 01:56 ET | 100 | 2.57 |
| 01:58 ET | 316 | 2.57 |
| 02:02 ET | 100 | 2.58 |
| 02:03 ET | 100 | 2.56 |
| 02:05 ET | 700 | 2.56 |
| 02:14 ET | 200 | 2.53 |
| 02:18 ET | 101 | 2.5325 |
| 02:21 ET | 107 | 2.5301 |
| 02:25 ET | 100 | 2.55 |
| 02:30 ET | 100 | 2.56 |
| 02:34 ET | 696 | 2.5401 |
| 02:36 ET | 518 | 2.53 |
| 02:41 ET | 2965 | 2.54 |
| 02:43 ET | 100 | 2.52 |
| 02:45 ET | 1150 | 2.51 |
| 02:50 ET | 1470 | 2.5 |
| 02:52 ET | 100 | 2.4822 |
| 02:54 ET | 100 | 2.47 |
| 02:59 ET | 745 | 2.445 |
| 03:03 ET | 5364 | 2.4614 |
| 03:06 ET | 3930 | 2.475 |
| 03:08 ET | 1520 | 2.4626 |
| 03:10 ET | 6661 | 2.45 |
| 03:12 ET | 3000 | 2.448 |
| 03:14 ET | 254 | 2.47 |
| 03:15 ET | 500 | 2.4336 |
| 03:26 ET | 399 | 2.48 |
| 03:30 ET | 100 | 2.485 |
| 03:33 ET | 6315 | 2.46 |
| 03:35 ET | 1100 | 2.475 |
| 03:42 ET | 400 | 2.48 |
| 03:44 ET | 500 | 2.48 |
| 03:46 ET | 100 | 2.47 |
| 03:48 ET | 2600 | 2.46 |
| 03:50 ET | 7377 | 2.44 |
| 03:51 ET | 500 | 2.4437 |
| 03:53 ET | 3149 | 2.45 |
| 03:55 ET | 1189 | 2.44 |
| 03:57 ET | 585 | 2.435 |
| 04:00 ET | 3830 | 2.43 |
Jan 20, 2023
PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event, from 1:31PM ET on Friday Jan 20, 2023 by GlobeNewswire
1:31PM ET on Friday Jan 20, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PaxMedica Inc | 29.2M | -8.5x | --- |
Purple Biotech Ltd | 29.1M | -0.1x | --- |
Edesa Biotech Inc | 28.6M | -1.2x | --- |
Goldenwell Biotech Inc | 28.3M | -286.4x | --- |
AgeX Therapeutics Inc | 29.8M | -3.0x | --- |
Lumos Pharma Inc | 28.9M | -1.0x | --- |
Company Information
PaxMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Its product candidates include PAX-101 and PAX-102. Its lead program, PAX-101, is an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders, such as ME/CFS and Long COVID-19 Syndrome (LCS). It is also focused on developing PAX-101 for the treatment of East African Human-African Trypanosomiasis (HAT), which is caused by the parasite Trypanosome brucei rhodesiense. It is also focused on developing PAX-102, which is an intranasal formulation of suramin for neurologic indications.
Contact Information
- Headquarters
- 303 South Broadway, Suite 125TARRYTOWN, NY, United States 10591
- Phone
- 914-987-2876
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- Michael Derby
- Chief Executive Officer, Director
- Howard Weisman
- Chief Financial Officer
- Stephen Sheldon
- Chief Operating Officer, Director
- Zachary Rome
- Independent Director
- Charles Casamento
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.28 |
Book Value | $-0.86 |
P/E Ratio | -8.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
